Literature DB >> 6864339

Dietary NaCl loads promote calciuria and bone loss in adult oophorectomized rats consuming a low calcium diet.

A Goulding, D Campbell.   

Abstract

This study was undertaken to determine whether dietary supplements of NaCl would exaggerate osteopenia in oophorectomized (OOPX) rats consuming a low calcium (0.01% Ca) diet. Thirty 300 g OOPX rats with 45Ca-labeled bones were studied. Animals in group 1 were killed at the start of the experiment, whereas those in groups 2 and 3 were fed a low calcium diet for 2 months. Group 3 rats received NaCl (8 g/100 g diet). Salt increased the urinary excretion of sodium, calcium, phosphate, cyclic AMP, 45Ca and hydroxyproline but did not augment fecal excretion of calcium or 45Ca. Salt caused bone loss. The femora of NaCl-treated rats contained less 45Ca, less calcium, less phosphate and less mineral ash than those of rats killed at the start of the experiment. It is suggested that in OOPX rats consuming a low calcium diet, increased NaCl intake causes decreased renal tubular reabsorption of calcium and consequently lowered plasma Ca++. This results in stimulation of parathyroid hormone secretion and thus increased bone resorption. We conclude that NaCl supplements exacerbate osteopenia in adult OOPX rats consuming a low calcium diet. The effects of high dietary salt intakes on bone loss in postmenopausal women deserve further study.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6864339     DOI: 10.1093/jn/113.7.1409

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  10 in total

Review 1.  Calcium supplementation of the diet: justified by present evidence.

Authors:  B E Nordin; R P Heaney
Journal:  BMJ       Date:  1990-04-21

2.  Higher habitual sodium intake is not detrimental for bones in older women with adequate calcium intake.

Authors:  Jasminka Z Ilich; Rhonda A Brownbill; Daniel C Coster
Journal:  Eur J Appl Physiol       Date:  2010-03-10       Impact factor: 3.078

Review 3.  Can parathyroid hormone be used as a biomarker for heart failure?

Authors:  Sumeet Gandhi; Robert B H Myers
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

4.  The effect of high sodium intake on bone mineral content in rats fed a normal calcium or a low calcium diet.

Authors:  A Y Chan; P Poon; E L Chan; S L Fung; R Swaminathan
Journal:  Osteoporos Int       Date:  1993-12       Impact factor: 4.507

5.  Relationship of nutrient intakes and bone mineral density of elderly women in Daegu, Korea.

Authors:  Mi-Ja Choi; Eun-Jin Park; Hyun-Ju Jo
Journal:  Nutr Res Pract       Date:  2007-12-31       Impact factor: 1.926

6.  Cadmium accelerates bone loss in ovariectomized mice and fetal rat limb bones in culture.

Authors:  M H Bhattacharyya; B D Whelton; P H Stern; D P Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide.

Authors:  J de Schepper; S Hachimi-Idrissi; O Louis; R Maurus; J Otten
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

8.  Higher urinary sodium, a proxy for intake, is associated with increased calcium excretion and lower hip bone density in healthy young women with lower calcium intakes.

Authors:  Jennifer L Bedford; Susan I Barr
Journal:  Nutrients       Date:  2011-11-10       Impact factor: 6.706

9.  Effect of Dietary Sodium and Potassium Intake on the Mobilization of Bone Lead among Middle-Aged and Older Men: The Veterans Affairs Normative Aging Study.

Authors:  Xin Wang; Douglas Kim; Katherine L Tucker; Marc G Weisskopf; David Sparrow; Howard Hu; Sung Kyun Park
Journal:  Nutrients       Date:  2019-11-13       Impact factor: 5.717

10.  Effects of a high-sodium diet on renal tubule Ca2+ transporter and claudin expression in Wistar-Kyoto rats.

Authors:  Midori Sasaki Yatabe; Junichi Yatabe; Kozue Takano; Yuta Murakami; Rina Sakuta; Sadahiko Abe; Hironobu Sanada; Junko Kimura; Tsuyoshi Watanabe
Journal:  BMC Nephrol       Date:  2012-12-02       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.